Nature Communications · 2020 · 49 citations · 39 references
Life SciencesMolecular BiologyOncologyCellular MetabolismMitochondrial BiologyMolecular OncologyMitochondrial BioenergeticsMitochondrial DisordersMitochondrial DysfunctionMitochondrial MetabolismMitochondrial PhysiologyMitochondrial Stress ResponsesDna Damage InductionHistone H2ax PhosphorylationMitochondrial Respiratory Complex IiMutator PhenotypesOxidative Dna DamagePrimary Cells
Recurrent somatic mutations in ETNK1 (Ethanolamine-Kinase-1) were identified in several myeloid malignancies and are responsible for a reduced enzymatic activity. Here, we demonstrate in primary leukemic cells and in cell lines that mutated ETNK1 causes a significant increase in mitochondrial activity, ROS production, and Histone H2AX phosphorylation, ultimately driving the increased accumulation of new mutations. We also show that phosphoethanolamine, the metabolic product of ETNK1, negatively controls mitochondrial activity through a direct competition with succinate at mitochondrial complex II. Hence, reduced intracellular phosphoethanolamine causes mitochondria hyperactivation, ROS production, and DNA damage. Treatment with phosphoethanolamine is able to counteract complex II hyperactivation and to restore a normal phenotype.
39
The Sequence Alignment/Map format and SAMtools
Heng Li, Alec Wysoker, Tim Fennell et al. · Bioinformatics · 2009 · 67.5K citations · Full text
Fast and accurate short read alignment with Burrows–Wheeler transform
Heng Li, Richard Durbin · Bioinformatics · 2009 · 62.8K citations · Full text
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran, Patrick D. Hsu, Jason Wright et al. · Nature Protocols · 2013 · 11.7K citations · Full text
KEGG: new perspectives on genomes, pathways, diseases and drugs
Minoru Kanehisa, Miho Furumichi, Mao Tanabe et al. · Nucleic Acids Research · 2016 · 9.4K citations · Full text